Palatin Technologies, Inc.
Therapies for Obesity, Diabetes and Related Indications

Abstract:

The invention relates to methods, uses, compositions and formulations including a melanocortin receptor-4 agonist and a glucagon-like peptide-1 receptor agonist for treatment of obesity, diabetes, metabolic syndrome and related indications, diseases or disorders.